Understanding DNA methylation has led to the development of therapeutic strategies, especially in cancer treatment. DNA methylation inhibitors such as 5-azacytidine and decitabine are used to reverse aberrant methylation patterns in certain leukemias and myelodysplastic syndromes. Research is ongoing to expand these therapies to other cancers and diseases.
